Overcoming Challenges When Developing And Manufacturing Minimally Invasive Cardiovascular Devices Requiring The Finest Textiles

The medical industry is seeing an increase in the use of smaller medical devices for minimally invasive therapies. However, the materials and components currently available are often too large for these devices. Ulteeva Purity™ fiber, a medical-grade fine UHMWPE fiber, offers a solution to this problem. This fiber is thinner and less bulky while still providing strength and durability. It is suitable for cardiovascular applications such as valve replacement devices and has a long history of clinical use.

Ulteeva Purity™ fiber meets the mechanical performance requirements for minimally invasive therapies and is produced in a dedicated medical production facility, ensuring adherence to medical standards and regulatory requirements. It is biocompatible and has shown to have a better biological response compared to other fibers.

By choosing Ulteeva Purity™ fiber, developers can create vascular products with lower crossing profiles, such as heart valves for TAVR procedures. This fiber can expedite the time to market for medical devices due to its long-term clinical history and adherence to quality, regulatory, and engineering standards. DSM Biomedical, with its expertise in polyethylene, offers support for textile development and is a trusted partner in the industry.

Learn how leveraging a partner with expertise developing and manufacturing a medical-grade fine UHMWPE fiber can accelerate time to market for your minimally invasive medical device.